We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Does Aviva plc Pass My Triple Yield Test?

Aviva plc (LON:AV) has made strong progress this year, but now faces flood losses.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

aviva

Like most private investors, I drip-feed money from my earnings into my investment account each month. To stay fully invested, I need to make regular purchases, regardless of the market’s latest gyrations.

Should you buy Aviva Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

However, the FTSE 100 is up 78%on its March 2009 low, and the wider market is no longer cheap. It’s getting harder to find shares that meet my criteria for affordability.

In this article, I’m going to run my investing eye over Aviva (LSE: AV) (NYSE: AV.US), to see if it might fit the bill.

The triple yield test

Today’s low interest rates mean that shares have become some of the most attractive income-bearing investments available.

To gauge the affordability of a share for my portfolio, I like to look at three key trailing yield figures –the dividend, earnings and free cash flow yields. I call this my triple yield test:

Aviva Value
Current share price 469p
Dividend yield 3.1%
Earnings yield -0.5%
Free cash flow yield 7.1%
FTSE 100 average dividend yield 2.8%
FTSE 100 earnings yield 5.7%
Instant access cash savings rate 1.5%
UK 10yr govt bond yield 2.8%

A share’s earnings yield is simply the inverse of its P/E ratio. Aviva’s trailing earnings yield is negative, as it has reported a loss for the last 12 months (H2 2012 and H1 2013), but the firm’s full-year results are due on 6 March, and Aviva is expected to report earnings of 41.6p per share, giving a prospective earnings yield of 8.9%, at the current share price.

Aviva’s share price has risen by 31% over the last year, reducing its dividend yield to a fairly average 3.1%. However, Aviva has managed to maintain strong cash flows, and its free cash flow yield of 7.1% suggests that CEO Mark Wilson’s focus on cash flow is paying off, and could support long-term dividend growth.

Is Aviva a buy?

Aviva is expected to have been hit hard by this winter’s widespread flooding. A report by Bank of America Merrill Lynch this week forecast that Aviva will face a loss of around £170m from the floods. However, a separate report published by Goldman Sachs suggests that Aviva’s reinsurance cover will limit losses to £150m, which while painful, shouldn’t do any lasting damage to Aviva’s turnaround plan.

Aviva is expected to increase its total dividend by 2.7% to 15.0p this year, giving a prospective yield of 3.2%. Although this is only a fraction of the yield which the firm used to provide, I believe that Aviva is a buy, as it is increasingly well-positioned to deliver stable long-term growth, and on a 2013 forecast P/E of 11.5, doesn’t look too expensive.

> Roland owns shares in Aviva but not in any of the other companies mentioned in this article.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Not sure what a SIPP is? 3 reasons it could pay to know!

Christopher Ruane digs into some of the details of a SIPP and highlights a trio of possible benefits he sees…

Read more »

Investing Articles

Lloyds shares have done nothing for almost half a year — are they stuck at £1?

Mark Hartley takes a closer look at why his Lloyds' shares have barely moved in 2026, but finds reassurance in…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Forget waiting for the IPOs: here’s how to invest in SpaceX and Anthropic today

SpaceX and Anthropic IPOs in 2026 are going to be huge. But investors don’t need to wait for them to…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

2 FTSE investment trusts to consider for passive income in 2026

Ben McPoland spotlights a pair of struggling investment trusts, one of which has crashed 50%. Why does he think they…

Read more »

Tesla car at super charger station
Investing Articles

How much impact could a SpaceX merger have on the Tesla share price?

A SpaceX IPO could be the biggest in history and if Musk's merger plans go ahead, it could save the…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

£5,000 invested in Greggs shares 2 years ago is now worth…

Greggs' shares have been a diabolical investment over the last two years. But could they offer value today given they’ve…

Read more »

Investing Articles

Down 26% this year! Should I keep buying shares in this UK growth company?

Is Judges Scientific still one of the UK’s top growth shares? Stephen Wright thinks it might be – despite a…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Could these 3 income shares really turn £20,000 into £119,162?

James Beard explains how reinvesting dividends from income shares could create huge long-term wealth, including for those investors starting later…

Read more »